COMMUNIQUÉS West-GlobeNewswire

Codexis Reports Financial Results for the Third Quarter of 2017

09/11/2017 - 22:05

Product sales increase 71% over the prior year Affirms 2017 revenue guidance Conference call begins at 4:30 pm Eastern time today REDWOOD CITY, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS ), a [...]

Sonoma Pharmaceuticals Reports Robust Top Line Growth for Second Quarter FY 2018 with 61% Product Revenue Growth and Total Revenue of $4.3 Million

09/11/2017 - 22:05

Product revenue up 15%, compared to the June 2017 quarter Prescriptions filled were up 42% over last year and up 14% over the June 2017 quarter to 19,660 EBITDA loss reduced to $2.3 million Cash on hand equals $10 [...]

The Joint Corp. Reports Third Quarter 2017 Financial Results

09/11/2017 - 22:05

- Grew Revenue to $6.5 Million, 19% Year-over-Year - Narrowed Net Loss by $2.2 Million - Achieved Positive Adjusted EBITDA for the First Time as a Public Company and for Corporate Clinics Segment SCOTTSDALE, Ariz., Nov [...]

Kura Oncology to Host Investor Day on November 16, 2017

09/11/2017 - 22:05

SAN DIEGO, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Kura Oncology, Inc., (Nasdaq: KURA ) a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced that it will [...]

Fortress Biotech Reports Third Quarter 2017 Financial Results and Recent Corporate Highlights

09/11/2017 - 22:05

NEW YORK, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO ) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology [...]

ICU Medical, Inc. Announces Third Quarter 2017 Results

09/11/2017 - 22:05

SAN CLEMENTE, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI ), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care [...]

Ovid Therapeutics Reports Third Quarter 2017 Financial Results and Corporate Progress

09/11/2017 - 22:05

NEW YORK, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID ), a biopharmaceutical company committed to developing medicines for patients with rare neurological diseases, today announced financial [...]

Cyclacel Pharmaceuticals Reports Third Quarter 2017 Financial Results

09/11/2017 - 22:05

BERKELEY HEIGHTS, N.J., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC ) (NASDAQ: CYCCP ) ("Cyclacel" or the "Company"), a biopharmaceutical company developing oral therapies that target [...]

Zosano Pharma Reports Third Quarter 2017 Financial Results and Operational Update

09/11/2017 - 22:05

First patient enrolled in long term safety study in November 2017 Phase 2/3 data presented at International Headache Society in September Clinical results published in two leading scientific journals Access to capital [...]

Yield10 Bioscience Announces Third Quarter 2017 Financial Results

09/11/2017 - 22:03

WOBURN, Mass., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN ) today reported financial results for the three and nine months ended September 30, 2017. “Over the course of 2017 we have focused [...]

CareDx Reports Third Quarter 2017 Financial Results

09/11/2017 - 22:02

BRISBANE, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ: CDNA ), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value [...]

Avinger Announces Third Quarter 2017 Results

09/11/2017 - 22:01

REDWOOD CITY, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ: AVGR ) (“Avinger” or the “Company”), a leading developer of innovative treatments for peripheral artery disease (PAD), today reported [...]

Altimmune Announces Third Quarter 2017 Financial Results and Provides Corporate Update

09/11/2017 - 22:01

Initiated a Phase 2 clinical trial with NasoVAX vaccine with initial data expected in first quarter 2018 Completed enrollment in its Phase 1 HepTcell clinical trial with data expected in fourth quarter 2017 Conference [...]

Stemline Therapeutics Reports Third Quarter 2017 Financial Results

09/11/2017 - 22:01

NEW YORK, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML ), a clinical-stage biopharmaceutical company developing novel therapeutics for difficult to treat cancers, announced today financial [...]

Endocyte to Present at the Jefferies 2017 London Healthcare Conference

09/11/2017 - 22:01

WEST LAFAYETTE, Ind., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ: ECYT ), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, today announced that the company’s [...]

Cellectar Biosciences Reports Third Quarter 2017 Financial and Corporate Performance

09/11/2017 - 22:01

MADISON, Wis., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB ), an oncology-focused, clinical stage biotechnology company (the “company”), today reported financial results and corporate [...]

Mersana Announces Third Quarter 2017 Financial Results and Provides Business Updates

09/11/2017 - 22:01

Received FDA Clearance of IND Application for XMT-1536, a First-in-Class Dolaflexin® Antibody Drug Conjugate Targeting NaPi2b XMT-1522 Phase 1 Trial Continues Enrollment of Patients with Advanced Tumors Expressing HER2 [...]

Zomedica Pharmaceuticals Corp. Announces Third Quarter 2017 Financial Results

09/11/2017 - 22:01

ANN ARBOR, Mich., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V: ZOM ) (“Zomedica” or “Company”), a veterinary pharmaceutical and health care solutions company, today reported condensed [...]

Bio-Path Holdings Reports Third Quarter 2017 Financial Results

09/11/2017 - 22:01

HOUSTON, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc. (NASDAQ: BPTH ), a biotechnology company leveraging its proprietary DNAbilize ® antisense RNAi nanoparticle technology to develop a portfolio of [...]